Astragalus shows genuine promise for kidney health, with both animal and human studies pointing to measurable improvements in kidney function. In one clinical study of 37 patients with mild to moderate chronic kidney disease, kidney filtration rates improved from an average of 66 to 70 mL/min after taking astragalus-containing preparations. That’s a modest but statistically significant gain, and it aligns with a growing body of lab and animal research showing the herb can reduce inflammation and scarring in kidney tissue.
That said, most of the strongest evidence still comes from animal models and small human studies. Astragalus is not a replacement for standard kidney care, but it may offer real benefits as a complementary supplement for certain people.
How Astragalus Protects Kidney Tissue
The two biggest threats to declining kidneys are chronic inflammation and fibrosis, which is the gradual replacement of healthy tissue with scar tissue. Astragalus works against both of these processes through several overlapping mechanisms.
One key pathway involves a signaling protein called TGF-beta, which drives the growth and migration of fibroblasts (the cells that produce scar tissue). In hypertensive mice with kidney damage, astragalus polysaccharides significantly reduced TGF-beta activity, which in turn lowered collagen deposits in the kidneys. Less collagen buildup means less scarring and better preservation of functional tissue.
On the inflammation side, astragalus reduces levels of pro-inflammatory molecules like IL-1 beta, IL-6, and TNF-alpha. These are chemical signals that recruit immune cells and sustain the kind of chronic, low-grade inflammation that slowly erodes kidney function over months and years. In animal models, astragalus treatment measurably dialed down this inflammatory response, leading to less kidney tissue damage.
Astragalus contains several active compounds, but two stand out for kidney protection. Astragalus polysaccharides (complex sugar molecules) drive much of the anti-inflammatory and anti-fibrotic activity. Astragaloside IV, a separate compound in the root, has been shown to inhibit harmful cell proliferation in kidney tissue and protect against chronic glomerulonephritis, a condition where the kidney’s filtering units become inflamed.
Evidence in Chronic Kidney Disease
The most direct human evidence comes from a self-controlled case series published in Frontiers in Pharmacology. Researchers tracked 37 patients with mild to moderate chronic kidney disease (stages 2 and 3) who were given oral astragalus root preparations. Their estimated glomerular filtration rate, the standard measure of how well the kidneys filter blood, improved from 66 to 70 mL/min on average. Blood markers like hemoglobin and albumin stayed stable, suggesting the improvement wasn’t coming at a cost to other body systems.
Animal studies reinforce these findings with more dramatic numbers. In a rat model of chronic kidney disease, creatinine clearance (another measure of kidney filtration) nearly doubled with astragalus treatment. Rats with CKD had clearance rates of 1.5 mL/min compared to 3.8 mL/min in healthy rats. After four weeks of astragalus, treated rats recovered to 2.5 to 2.7 mL/min, depending on the dose. That’s a substantial recovery of lost function.
Benefits for Diabetic Kidney Disease
Diabetes is the leading cause of kidney disease worldwide, and astragalus appears particularly relevant here. In rats with diabetic nephropathy (kidney damage caused by diabetes), astragalus polysaccharides reduced fasting blood sugar, lowered protein leaking into the urine, and reversed some of the physical enlargement of the glomeruli, the tiny filtering structures inside the kidneys. Protein in the urine is one of the earliest warning signs that diabetes is starting to damage the kidneys, so reducing it is a meaningful outcome.
The mechanism in diabetic kidney disease involves a cellular cleanup process called autophagy, where damaged components inside cells are broken down and recycled. Diabetes disrupts autophagy in podocytes, the specialized cells that form the kidney’s filtration barrier. Astragalus polysaccharides reactivate this process, helping podocytes clear out damage and maintain their structure. When these cells deteriorate, protein starts leaking through the filter and into the urine.
Safety and Who Should Be Cautious
Astragalus has a long safety track record in traditional Chinese medicine and is listed as a dietary ingredient in the US Pharmacopeia. In clinical trial protocols for diabetic kidney disease, researchers include patients with eGFR values between 30 and 90 mL/min, which covers moderate kidney impairment. However, patients with very advanced kidney disease or severely elevated protein in the urine (albumin-to-creatinine ratios above 5,000 mg/g) are typically excluded from studies, meaning safety data in late-stage kidney failure is limited.
Clinical trials routinely monitor liver and kidney function 4 to 6 weeks after starting astragalus to watch for any acute changes. Serious adverse events leading to treatment discontinuation appear rare in published research, though hypersensitivity reactions are possible.
One important consideration involves the immune system. Astragalus has immunomodulatory properties, meaning it can shift immune activity. For people taking immunosuppressive medications, particularly after a kidney transplant or for autoimmune kidney conditions like lupus nephritis, this creates a potential conflict. Some studies have combined astragalus with immunosuppressants like cyclophosphamide and mycophenolate under medical supervision, but this is not something to attempt on your own. If you take any medication that suppresses your immune system, discuss astragalus with your prescribing doctor before adding it.
Dosage Used in Studies
There is no universally agreed-upon dose of astragalus for kidney support, and the forms used in research vary widely. Animal studies showing kidney benefits have used dried astragalus root at doses equivalent to 400 to 800 mg per kilogram of body weight per day in rats. These doses don’t translate directly to human use, but they establish that higher doses tend to produce somewhat better results than lower ones.
Human studies have primarily used astragalus-containing herbal preparations rather than isolated extracts, making it difficult to pin down an exact effective dose of astragalus alone. Traditional Chinese medicine practitioners typically prescribe the dried root in doses ranging from 9 to 30 grams per day, often in combination with other herbs. Standardized extract capsules sold as supplements contain far less, often 500 to 1,500 mg per day.
If you’re considering astragalus for kidney health, the form matters. Soluble herbal granules produced under Good Manufacturing Practice standards, like those used in university-led clinical trials, offer more consistency than bulk herbs of unknown origin. Look for products with third-party testing or pharmacopeial registration.
What the Evidence Adds Up To
Astragalus is not a proven treatment for kidney disease in the way that blood pressure medications or blood sugar control are. The human data, while encouraging, comes from small studies without placebo controls. But the biological mechanisms are well documented across dozens of animal studies: less inflammation, less scarring, better preservation of the kidney’s filtering structures, and in diabetic models, reduced protein leakage.
For people with mild to moderate chronic kidney disease or early diabetic kidney damage, astragalus represents a reasonable complementary option with a favorable safety profile. For those with advanced kidney failure, transplant history, or autoimmune kidney conditions, the risk-benefit picture is less clear and requires medical guidance.